Description
Composition- Amoxycillin 875 mg + Potassium Clavulanate 125 mg
Mode of Action- Amoxycillin inhibits bacterial cell wall synthesis while Clavulanate inhibits β-lactamase enzymes, extending antibacterial coverage against resistant organisms.
USPs- Broad-spectrum coverage including resistant strains; effective in severe respiratory and systemic infections; reliable high-dose therapy with proven clinical efficacy.
Prescribing Specialties- Physician, Pulmonologist, ENT Specialist, Internal Medicine
